Rocket Lab CFO Adam Spice sells $8.78 million in company stock By Investing.com

Rocket Lab () Chief Financial Officer Adam Spice sold common stock valued at approximately $8.78 million on September 2, 2026. The transactions involved the sale of 140,157 shares, with prices ranging from $61.5900 to $63.4700 per share. These sales followed the acquisition of the same number of shares through the exercise of employee stock options at a price of $1.09 per share, totaling $152,771. The stock currently trades at $64.26, down 43% from its 52-week high of $151, though it has delivered a 49.48% return over the past year. According to InvestingPro analysis, the stock appears overvalued at current levels, placing it among the most overvalued stocks tracked by the platform.

The sales were executed in two separate transactions. One involved 67,257 shares sold at a weighted-average price of $62.2564, with individual prices ranging from $61.5900 to $62.5800. The second transaction saw 72,900 shares sold at a weighted-average price of $62.9704, with prices ranging from $62.5900 to $63.4700. These dispositions were carried out automatically under a pre-arranged Rule 10b5-1 trading plan, which Mr. Spice adopted on June 3, 2026.

The shares sold were acquired through the exercise of an employee stock option granted on August 3, 2018. The option had a vesting commencement date of May 25, 2018, with shares vesting over time, subject to Mr. Spice’s continued service. The exercise price for these options was $1.09 per share.

Following these reported transactions, Mr. Spice directly holds 1,155,967 shares of Rocket Lab common stock. Additionally, 250,000 shares are indirectly beneficially owned by a Trust. Mr. Spice also retains employee stock options to purchase 2,382,668 shares, with an exercise price of $1.09 and an expiration date of August 3, 2028. For investors seeking deeper insights into Rocket Lab’s financial health and future prospects, InvestingPro offers a comprehensive Pro Research Report covering this and over 1,400 US equities, transforming complex data into actionable intelligence.

In other recent news, Rocket Lab USA has been making significant strides in its financial and strategic operations. The company reported second-quarter revenue that was 1% above consensus estimates, marking a 62% increase year-over-year. This strong performance led Needham to reiterate a Buy rating with a price target of $120.00. Cantor Fitzgerald also raised its price target to $122.00, highlighting Rocket Lab’s record second-quarter revenue of approximately $234.1 million and noting the progress of its Neutron rocket, which is on track for its first launch later this year.

Additionally, Rocket Lab has filed financial and pro forma statements with the Securities and Exchange Commission related to its pending acquisition of . This merger involves complex structural changes, ultimately making Iridium an indirect wholly owned subsidiary of Rocket Lab. KeyBanc maintained its Overweight rating on the company, citing accelerating momentum in Space Systems and costs associated with the Neutron program.

Berenberg initiated coverage on Rocket Lab with a Buy rating and a price target of $83.00, noting the company’s dominance in the space sector. These developments reflect Rocket Lab’s ongoing efforts to strengthen its position in the industry and expand its capabilities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.